The latest information for December 10, 2020


To view this email online, paste this link into your browser:
[link removed]





([link removed])

Thursday, December 10, 2020

DONATE ([link removed])

Cystic Fibrosis Foundation
4550 Montgomery Ave, Suite 1100N
Bethesda, Maryland 20814

www.cff.org ([link removed])

First Global Study of COVID-19 in Children With Cystic Fibrosis Reports Reassuring Outcomes

The Cystic Fibrosis Registry Global Harmonization Group, including the Cystic Fibrosis Foundation, recently published findings from the first global study ([link removed]) on the impact of COVID-19 on children with cystic fibrosis in the Journal of Cystic Fibrosis. The manuscript reports on 105 children under the age of 18 with CF from 13 countries and concludes that COVID-19 is usually associated with mild illness in children without severe pre-existing lung disease, offering a significantly more reassuring outlook than originally anticipated at the start of the global pandemic. 

Read about the study » ([link removed])

([link removed])

CF Foundation Funds 11 Laboratory Studies Exploring Underlying Factors that Impact COVID-19 

As part of our comprehensive focus on fighting infections, the Foundation announced this week more than $2.7 million to support 11 laboratory studies ([link removed]) that will explore the underlying factors that could impact COVID-19 outcomes in people with cystic fibrosis. Ultimately, insights gained from this body of research may be used to improve future treatments.

Read about the announcement » ([link removed])

CF Foundation Awards $1.7M in New Funding Under Path to a Cure Initiative

This week the Foundation announced $1.7 million in new research ([link removed]) funding to drive progress on our Path to a Cure. The awards, to seven academic institutions and two companies, will support focused research into key scientific challenges associated with developing therapies to address the underlying cause of disease for all people with CF, regardless of their underlying mutation. 

Read about the awards » ([link removed])

([link removed])

CF Foundation Awards Up to $3.3M to Polyphor for Inhaled Version of Antibiotic to Treat Pseudomonas

We awarded up to $3.3 million to ([link removed]) Polyphor ([link removed]) to develop an inhaled version of murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in people with cystic fibrosis. Funding will support a Phased 1b/2a clinical trial in adults with CF, which is expected to start in the fourth quarter of 2021 following a study in healthy volunteers.

Read the announcement » ([link removed])

Together: Curing CF Recording is Now Available

The recording from our first national Breath of Life Celebration ([link removed]) is now available. The event honored Preston W. Campbell III, MD, former president and CEO of the Foundation, for his transformative contributions over the past three decades in advancing research and care for people with CF. Watch to hear from members of the CF community, including Joe O’Donnell, Wells and Kelli Clark, and from entertainers and long-time supporters such as Lewis Black, Victoria Shaw, and Matt Rogers.

Watch on YouTube » ([link removed])





4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US

This email was sent to [email protected].
To ensure that you continue receiving our emails,
please add us to your address book or safe list.

manage your preferences ([link removed])
opt out ([link removed]) using TrueRemove(r).

Got this as a forward? Sign up ([link removed]) to receive our future emails.
email powered by Emma(R)
[link removed]